DNA microarrays in prostate cancer

Current Urology Reports

Volumn 3, Issue 1, 2002, Pages 53-60

  Ho, Shuk Mei ^a   Lau, Kin Mang ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Benign Prostatic Hyperplasia; cDNA Microarray; Human Prostate Cancer; Laser Capture Microdissection; Prostate Cancer

Indexed keywords

ALGORITHM; ARTIFICIAL NEURAL NETWORK; DNA MICROARRAY; GENETICS; HUMAN; MALE; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RESEARCH; REVIEW;

ALGORITHMS; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RESEARCH;

EID: 0036483670     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-002-0011-x     Document Type: Article

References (54)

1. American Cancer Society: Cancer facts and figures 2001. http://www.cancer.org/eprise/main/docroot/stt/stt_0.
2. Peters KF, Menaker TJ, Wilson PL, Hadley DW: The Human Genome Project: an update. Cancer Nurs 2001, 24:287–292; quiz 292–293. DOI: 10.1097/00002820-200108000-00007
3. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467–470. DOI: 10.1126/science.270.5235.467
4. Fields C, Adams MD, White O, Venter JC: How many genes in the human genome? Nat Genet 1994, 7:345–346. DOI: 10.1038/ng0794-345
5. Bishop JO, Morton JG, Rosbash M, Richardson M: Three abundance classes in HeLa cell messenger RNA. Nature 1974, 250:199–204. DOI: 10.1038/250199a0
6. Chaib H, Cockrell EK, Rubin MA, Macoska JA: Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 2001, 3:43–52. DOI: 10.1038/sj.neo.7900126
7. Emmert-Buck MR, Strausberg RL, Krizman DB, et al.: Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn 2000, 2:60–66. An excellent review of the resources available for DNA microarray and complementary technologies for molecular studies of the biological basis of prostate cancer.
8. Svaren J, Ehrig T, Abdulkadir SA, et al.: EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 2000, 275:38524–38531. DOI: 10.1074/jbc.M005220200
9. Calaluce R, Kunkel MW, Watts GS, et al.: Laminin-5-mediated gene expression in human prostate carcinoma cells. Mol Carcinog 2001, 30:119–129. DOI: 10.1002/1098-2744(200102)30:2<119::AID-MC1020>3.0.CO;2-N
10. Ouyang XS, Wang X, Lee DT, et al.: Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis 2001, 22:965–973. DOI: 10.1093/carcin/22.6.965
11. Asamoto M, Hokaiwado N, Cho YM, et al.: Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 2001, 61:4693–4700.
12. Amler LC, Agus DB, LeDuc C, et al.: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 2000, 60:6134–6141.
13. Lin B, White JT, Ferguson C, et al.: Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium. Cancer Res 2001, 61:1611–1618.
14. Hawkins V, Doll D, Bumgarner R, et al.: PEDB: the Prostate Expression Database. Nucleic Acids Res 1999, 27:204–208. DOI: 10.1093/nar/27.1.204
15. Cole KA, Krizman DB, Emmert-Buck MR: The genetics of cancer—a 3D model. Nat Genet 1999, 21(suppl 1):38–41. DOI: 10.1038/4466
16. Elek J, Park KH, Narayanan R: Microarray-based expression profiling in prostate tumors. In Vivo 2000, 14:173–182.
17. Chaib H, Rubin MA, Mucci NR, et al.: Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res 2001, 61:2390–2394.
18. Chetcuti A, Margan S, Mann S, et al.: Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate 2001, 47:132–140. DOI: 10.1002/pros.1056
19. Bull JH, Ellison G, Patel A, et al.: Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 2001, 84:1512–1519. A comprehensive study involving DNA microarray analysis on clinical samples and successful identification of potential prostate/ PIN-specific markers. DOI: 10.1054/bjoc.2001.1816
20. Nagle RB: New molecular approaches to tissue analysis. J Histochem Cytochem 2001, 49:1063–1064. This paper presents some laser capture microdissection and RNA amplification as complementary technologies to DNA microarray.
21. Xu J, Stolk JA, Zhang X, et al.: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000, 60:1677–1682. An innovative combination of technologies to allow for identification of prostate- and prostate cancer-specific biomarkers.
22. Carlisle AJ, Prabhu VV, Elkahloun A, et al.: Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol Carcinog 2000, 28:12–22. DOI: 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q
23. Verma RS, Manikal M, Conte RA, Godec CJ: Chromosomal basis of adenocarcinoma of the prostate. Cancer Invest 1999, 17:441–447. DOI: 10.3109/07357909909021436
24. Ross RK: The role of molecular genetics in chemoprevention studies of prostate cancer. IARC Sci Publ 2001, 154:207–213.
25. Wang DG, Fan JB, Siao CJ, et al.: Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998, 280:1077–1082. DOI: 10.1126/science.280.5366.1077
26. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 1999, 21:20–24. The authors review the technology and applications of in situ synthetic oligonucleotide microarray. Applications of DNA microarrays for large-scale genotyping and detection of gene mutation are well described and discussed in this article. DOI: 10.1038/4447
27. Ozen M, Pathak S: Genetic alterations in human prostate cancer: a review of current literature. Anticancer Res 2000, 20:1905–1912.
28. Hacia JG: Resequencing and mutational analysis using oligonucleotide microarrays. Nat Genet 1999, 21:42–47. This paper describes the use of DNA microarray for DNA sequencing studies and its principle. DOI: 10.1038/4469
29. Hui AB, Lo KW, Yin XL, et al.: Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 2001, 81:717–723. DOI: 10.1038/labinvest.3780280
30. Hegde P, Qi R, Abernathy K, et al.: A concise guide to cDNA microarray analysis. Biotechniques 2000, 29:548–556. This paper outlines the steps of cDNA microarray analysis and discusses each step in detail.
31. Yang YH, Dudoit S, Luu P, Speed TP: Normalization for cDNA microarray data. Proceedings of the International Society for Optical Engineering International Biomedical Optics Symposium 2001. San Jose, CA; January 2001. Different ways to normalize the DNA microarray data are presented and compared. The mathematical computations and principles of data normalization are described.
32. Vaarala MH, Porvari K, Kyllonen A, Vihko P: Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 2000, 80:1259–1268. DOI: 10.1038/labinvest.3780134
33. Raychaudhuri S, Stuart JM, Altman RB: Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 2000, 455–466.
34. Hilsenbeck SG, Friedrichs WE, Schiff R, et al.: Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. J Natl Cancer Inst 1999, 91:453–459. This is the first paper using principal component analysis on DNA microarray data to identify the differentially expressed genes related to tamoxifen-resistant breast cancer. DOI: 10.1093/jnci/91.5.453
35. Khan J, Simon R, Bittner M, et al.: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998, 58:5009–5013.
36. Luo J, Duggan DJ, Chen Y, et al.: Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 2001, 61:4683–4688.
37. Lu J, Liu Z, Xiong M, et al.: Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001, 91:288–294. DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1063>3.0.CO;2-S
38. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863–14868. The hierarchical clustering was, for the first time, used to analyze DNA microarray data for gene clustering. The authors wrote CLUSTER and TREEVIEW programs that are available to the public. DOI: 10.1073/pnas.95.25.14863
39. Bertucci F, Houlgatte R, Benziane A, et al.: Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000, 9:2981–2991. DOI: 10.1093/hmg/9.20.2981
40. Ross DT, Scherf U, Eisen MB, et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227–235. DOI: 10.1038/73432
41. Getz G, Levine E, Domany E: Coupled two-way clustering analysis of gene microarray data. Proc Natl Acad Sci U S A 2000, 97:12079–12084. DOI: 10.1073/pnas.210134797
42. Welsh JB, Zarrinkar PP, Sapinoso LM, et al.: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001, 98:1176–1181. DOI: 10.1073/pnas.98.3.1176
43. Dhanasekaran SM, Barrette TR, Ghosh D, et al.: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822–826. This paper presents the accurate classification of prostate tissue samples based on the patterns of gene expression profiles by DNA microarray analysis. In addition, the differentially expressed genes related to the phenotypes of the tissue samples were identified by t-statistics. DOI: 10.1038/35090585
44. Ward JH: Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963, 58:236–262. DOI: 10.2307/2282967
45. Hartigan JA: Clustering Algorithms. New York: John Wiley and Sons; 1975. This book presents different clustering algorithms and the mathematical computations for measurement of similarity or dissimilarity of multidimensional data.
46. Callow MJ, Dudoit S, Gong EL, et al.: Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res 2000, 10:2022–2029. This paper presents t-statistics for DNA microarray data analysis to identify the statistically significant, differentially expressed genes. Using the Q-Q plot, the genes with differential expression are clearly visualized. DOI: 10.1101/gr.10.12.2022
47. Lau KM, Thompson C, Tian W, Ho SM: Identification of differentially expressed genes in the ventral prostates of young and old rats using t-statistic analysis on cDNA microarray data, submitted.
48. Tamayo P, Slonim D, Mesirov J, et al.: Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999, 96:2907–2912. The principal advantages over hierarchical clustering of selforganizing maps were well presented. The authors are one of the first groups using self-organizing maps to analyze DNA microarray data. DOI: 10.1073/pnas.96.6.2907
49. Tavazoie S, Hughes JD, Campbell MJ, et al.: Systematic determination of genetic network architecture. Nat Genet 1999, 22:281–285. DOI: 10.1038/10343
50. Toronen P, Kolehmainen M, Wong G, Castren E: Analysis of gene expression data using self-organizing maps. FEBS Lett 1999, 451:142–146. The principle of self-organizing maps was well presented. The authors are one of the first groups using self-organizing maps to analyze DNA microarray data. DOI: 10.1016/S0014-5793(99)00524-4
51. Khan J, Wei JS, Ringner M, et al.: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7:673–679. This paper presents the successful use of artificial neural networks to train the machine to recognize the patterns of gene expression profiles of different types of small, round blue cell tumors of childhood and to accurately predict the cancer types of the blinded samples. DOI: 10.1038/89044
52. Mukherjee S, Tamayo P, Mesirov JP, et al.: Support vector machine classification of microarray data [technical report CBCL paper 182/AI memo 1676]. Cambridge, MA: Massachusetts Institute of Technology; 1999.
53. Furey TS, Cristianini N, Duffy N, et al.: Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000, 16:906–914. This paper presents the use of support vector machines to recognize the patterns of gene expression profiles of cancer tissue samples. The principles and mathematic computations of support vector machines are well described. DOI: 10.1093/bioinformatics/16.10.906
54. Brown MP, Grundy WN, Lin D, et al.: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A 2000, 97:262–267. DOI: 10.1073/pnas.97.1.262